Background: The use of smart pump technology has shown to be profitable in the intensive care unit (ICU) because it avoids costs from prevented medication errors and allows for savings on disposables and medications by establishing standardized concentrations and dosing units. Objective: The objective of the study is to evaluate the economic impact of the implementation of smart infusion pumps in the consumption of intravenous (IV) solutions in an ICU. Methods: A retrospective observational study was conducted with a pre-post design. The study occurred in the adult ICU of the Hospital Juárez de México. The pattern of consumption of IV solutions (sodium chloride 9%, Hartmann’s solution, dextrose 5% and 10%, sodium chloride 0.9% with dextrose 5%) was analyzed preimplementation and postimplementation of 50 Plum A+™ pumps with Hospira MedNet™ security software. Using the TreeAge Pro 2016 software, deterministic and probabilistic analyses were carried out (10 000 Monte Carlo simulations) to confirm the robustness of the annual consumption comparison and the associated expenses before and after implementing smart technology. Results: The implementation of the smart pumps reduced the annual consumption of IV solutions to 8994 units (18%) and 3649 liters (22.3%). In the first year, MXN$55 850.97 were saved. From an institutional perspective and with a probability of 0.63, the use of MedNet™ technology proved to be a lower cost alternative (17.1% saved) with respect to the conventional infusion systems. Conclusion: The implementation of smart infusion pumps allows savings, specifically for the IV solutions used in ICU.
HuschMSullivanCRooneyDet al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14:80-86.
2.
MoyenECamiréEStelfoxHT.Clinical review: medication errors in critical care. Crit Care. 2008;12:208.
3.
ForniAChuHFanikosJ.Technology utilization to prevent medication errors. Curr Drug Saf. 2010;5:13-18.
4.
SchillingMSandovalS.Impact of intelligent intravenous infusion pumps on directing care toward evidence-base standards: a retrospective data analysis. Hosp Pract. 2011;39:113-121.
5.
SkledarSNiccolaiCSchillingDet al. Quality-improvement analytics for intravenous infusion pumps. Am J Health Syst Pharm. 2013;70:680-686.
6.
Ucha-SamartínMPichel-LoureiroAVázquez-LópezCÁlvarez PayeroMPérez ParenteDMartínez-López de CastroN.Impacto económico de la resolución de problemas relacionados con medicamentos en un servicio de urgencias. Farm Hosp. 2013;37:59-64.
7.
RothschildJMKeohaneCACookEFet al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33:533-540.
8.
HardingAD.Increasing the use of “smart” pump drug libraries by nurses: a continuous quality improvement project. Am J Nurs. 2012;112:26-35.
9.
MansfieldJJarrettS.Using smart pumps to understand and evaluate clinician practice patterns to ensure patient safety. Hosp Pharm. 2013;48:942-950.
10.
OhashiKDalleurODykesPCBatesDW.Benefits and risks of using smart pumps to reduce medication error rates: a systematic review. Drug Saf. 2014;37:1011-1020.
11.
DanelloSHMaddoxRRSchaackGJ.Intravenous infusion safety technology return on investment. Hosp Pharm. 2009;44:680-688.
12.
HardingADConnollyMWWilkersonTO.Nurses’ risk without using smart pumps. JONAS Healthc Law Ethics Regul. 2011;13:17-20.
13.
Manrique-RodríguezSSánchez-GalindoACFernández-LlamazaresCMCalvo-CalvoMMCarrillo-Álvarez Sanjurjo-SáezÁM.Administración segura de medicamentos intravenosos en pediatría: 5 años de experiencia de una Unidad de Cuidados Intensivos Pediátricos con bombas de infusión inteligentes. Med Intensiva. 2016;40:411-421.
14.
PhelpsPK.Smart Infusion Pumps: Implementation, Management, and Drug Libraries. 2nd ed.Bethesda, MD: American Society of Health-System Pharmacists; 2016.
15.
Manrique-RodríguezSSánchez-GalindoACLópez-HerceJet al. Implementing smart pump technology in a pediatric intensive care unit: a cost-effective approach. Int J Med Inform. 2014;83:99-105.
16.
Puértolas-BalintFIbarra-PérezRSoria-CedilloIFet al. Costos evitados por bombas de infusión inteligentes al interceptar errores por sobredosificación de insulina en una unidad de cuidados intensivos. Rev Mex Cienc Farm. 2016;47:40-56.
17.
Portal de compras del Instituto Mexicano del Seguro Social (IMSS). México DF: IMSS. Date unknown. http://compras.imss.gob.mx/. Accessed September 27, 2016.
PedersenCASchneiderPJScheckelhoffDJ.ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2011. Am J Health Syst Pharm. 2012;69:768-785.
20.
Secretaría de Salud de México. Norma Oficial Mexicana NOM-022-SSA3-2012, que instituye las condiciones para la Administración de la Terapia de Infusión en los Estados Unidos Mexicanos. México DF: Diario Oficial de la Federación. http://www.dof.gob.mx/normasOficiales/4875/salud3a14_C/salud3a14_C.html/. Published 2012. Accessed February 5, 2018.
21.
Ibarra-PérezRPuértolas-BalintFLozano-CruzEZamora-GómezSECastro-PastranaLI.Intravenous administration errors intercepted by smart infusion technology in an adult intensive care unit [published online ahead of print April 1, 2017]. J Patient Saf. doi:10.1097/PTS.0000000000000374.
22.
MoránRADespaigneALGonzálezACAguilarRD.Costo-beneficio en una unidad de cuidados intensivos neonatales. Rev Cubana Pediatr. 2011;83:166-172.
23.
TanSSBakkerJHoogendoornMEet al. Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology. Value Health. 2012;15:81-86.
24.
Van der SluijsAFVan Slobbe-BijlsmaERChickSEVroomMBDongelmansDAVlaarAP.The impact of changes in intensive care organization on patient outcome and cost-effectiveness—a narrative review. J Intensive Care. 2017;5:13.
25.
FlanneryAHPandyaKLaineMEAlmeterPJFlynnJD.Managing the rising costs and high drug expenditures in critical care pharmacy practice. Pharmacotherapy. 2017;37:54-64.
26.
HalpernNAPastoresSM.Critical care medicine in the United States 2000–2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med. 2010;38:65-71.
27.
WeberRJKaneSLOrioloVASaulMSkledarSJDastaJF.Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med. 2003;31:S17-S24.
28.
LarsenGYParkerHBCashJO’ConnellMGrantMC.Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients. Pediatrics. 2005;116:e21-e15.
29.
WalrothTADossettHADoolinMet al. Standardizing concentrations of adult drug infusions in Indiana. Am J Health Syst Pharm. 2017;74:491-497.
30.
Arenas-LópezSStanleyIMTunstellPet al. Safe implementation of standard concentration infusions in paediatric intensive care. J Pharm Pharmacol. 2017;69:529-536.
31.
KaneSLWeberRJDastaJF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691-698.
